list of glp-1 agonists glp 1 inhibitors GLP-1-based therapies: current knowledge differences between native Diabetes mellitus: drugs A – GLP-1 Agonist List: An Overview

(N=22 older men) demonstrated that nightly subcutaneous sermorelin increased mean plasma IGF-1 by roughly 30% over 6 months [1]

Corazzini V, Salvatori R

Commonly Reported (Mild) Injection site irritation (redness, slight swelling, or tenderness) Mild headache or dizziness Temporary fatigue or feeling a bit off during or right after the cycle Occasional nausea (rare, usually mild) Less Common / Theoretical Because Epitalon activates telomerase, some researchers note a theoretical risk of abnormal cell growth

Downregulation of specific proteins/enzymes has also been demonstrated to disrupt the intestinal barrier, resulting in inflammation and elevated apoptotic genes

Analysis was performed using Students t test, single comparison, or analysis of variance (ANOVA) test for multiple comparisons (one-way or two-way ANOVA followed by Tukeys or Bonferronis multiple comparisons test, respectively)